About
Jenny is an associate in our Global M&A and Capital practice in New York. Her practice focuses on corporate and financial transactions, particularly mergers and acquisitions.
Additional Information
- Cencora (f/k/a AmerisourceBergen) on its pending $3.5 billion merger of its animal health division, MWI Animal Health, with Covetrus, Inc.
- Merck on its pending $10 billion acquisition of Verona Pharma plc.
- Leggett & Platt on the pending $285m sale of its Aerospace Products Group to Tinicum.
- Novartis on its pending €2.7 billion acquisition of MorphoSys AG.
- AstraZeneca on its $1.2 billion acquisition of Gracell Biotechnologies Inc.
- Li-Cycle in connection with its adoption of a limited duration shareholder rights plan.
- Blackstone portfolio company, Schenck Process Group, on the sale of its food and performance materials business to Hillenbrand, Inc.
- Molekule Group on its all-stock merger with Aura Smart Air.
- London Stock Exchange Group on its acquisition of AcadiaSoft.
- CarLotz on its sale to Shift Technologies.
- Zymergen on its pending $300 million sale to Ginkgo Bioworks.
Jenny Park
Associate
New York Office
3 World Trade Center
175 Greenwich Street, 51st Floor
New York, NY 10007